Veru Inc. Files 8-K for Material Agreement
Ticker: VERU · Form: 8-K · Filed: Oct 30, 2025 · CIK: 863894
Sentiment: neutral
Topics: material-agreement, 8-k, corporate-filing
TL;DR
VERU entered a material definitive agreement, filing 8-K today.
AI Summary
Veru Inc. filed an 8-K on October 30, 2025, reporting an entry into a material definitive agreement and other events. The filing also includes financial statements and exhibits. The company, previously known as Female Health Co. and Wisconsin Pharmacal Company Inc., is incorporated in Wisconsin and headquartered in Miami, Florida.
Why It Matters
This 8-K filing indicates Veru Inc. has entered into a significant agreement, which could impact its business operations and financial standing.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that may affect the company's stock price.
Key Players & Entities
- Veru Inc. (company) — Registrant
- Female Health Co. (company) — Former company name
- Wisconsin Pharmacal Company Inc. (company) — Former company name
- October 29, 2025 (date) — Earliest event reported
- October 30, 2025 (date) — Date of report
- Miami, Florida (location) — Principal executive offices
FAQ
What is the nature of the material definitive agreement entered into by Veru Inc.?
The filing states an 'Entry into a Material Definitive Agreement' as an item of disclosure, but the specific details of the agreement are not provided in this summary.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on October 29, 2025.
What is Veru Inc.'s principal executive office address?
Veru Inc.'s principal executive offices are located at 2916 N. Miami Avenue, Suite 1000, Miami, Florida 33127.
What were Veru Inc.'s former company names?
Veru Inc. was formerly known as Female Health Co. and Wisconsin Pharmacal Company Inc.
What is the SIC code for Veru Inc.?
The Standard Industrial Classification (SIC) code for Veru Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 2,009 words · 8 min read · ~7 pages · Grade level 11.7 · Accepted 2025-10-30 16:15:01
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value per share VERU NASDAQ Cap
- $0.001 — of Common Stock at an exercise price of $0.001 (the "Pre-Funded Warrants") in lieu the
- $3.00 — of Common Stock at an exercise price of $3.00 per share of Common Stock (the "Series
- $23.4 m — fering are expected to be approximately $23.4 million, after deducting the underwriting
- $4.00 — s of the Common Stock has been at least $4.00 for at least ten consecutive trading da
Filing Documents
- d59421d8k.htm (8-K) — 41KB
- d59421dex11.htm (EX-1.1) — 222KB
- d59421dex41.htm (EX-4.1) — 89KB
- d59421dex42.htm (EX-4.2) — 86KB
- d59421dex43.htm (EX-4.3) — 88KB
- d59421dex51.htm (EX-5.1) — 12KB
- d59421dex52.htm (EX-5.2) — 10KB
- d59421dex991.htm (EX-99.1) — 8KB
- d59421dex992.htm (EX-99.2) — 9KB
- g59421g1030121357215.jpg (GRAPHIC) — 3KB
- g59421g1030123117280.jpg (GRAPHIC) — 2KB
- g59421g98d55.jpg (GRAPHIC) — 5KB
- 0001193125-25-258565.txt ( ) — 846KB
- veru-20251029.xsd (EX-101.SCH) — 3KB
- veru-20251029_lab.xml (EX-101.LAB) — 18KB
- veru-20251029_pre.xml (EX-101.PRE) — 11KB
- d59421d8k_htm.xml (XML) — 4KB
Forward-Looking Statements
Forward-Looking Statements This report contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this report can be identified by the use of forward-looking words or phrases such as "anticipate," "believe," "could," "expect," "intend," "may," "opportunity," "plan," "predict," "potential," "estimate," "should, " "will," "would" or the negative of these terms or other words of similar meaning. Any forward-looking statements in this release are based upon the Company's current plans and strategies and reflect the Company's current assessment of the risks and uncertainties related to its business and are made as of the date of this report. The Company assumes no obligation to update any forward-looking statements contained in this release because of new information or future events, developments or circumstances. Such forward-looking statements are subject to known and unknown risks, uncertainties and assumptions, and if any such risks or uncertainties materialize or if any of the assumptions prove incorrect, the Company's actual results could differ materially from those expressed or implied by such statements. Factors that may cause actual results to differ materially from those contemplated by such forward-looking statements include, but are not limited to, uncertainties related to market conditions and the satisfaction of customary closing conditions related to the proposed public offering and the Company's expectations regarding the use of proceeds therefrom. This list is not exhaustive and other risks are detailed in the Company's periodic reports filed with the SEC, including the Company's Form 10-K for the year ended September 30, 2024 and in the Company's subsequent Quarterly Reports on Form 10-Q, which are available at www.sec.gov. Item9.01
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits . Exhibit No. Document 1.1 Underwriting Agreement dated October 30, 2025, by and between Veru Inc. and the underwriters named therein. 4.1 Form of Pre-Funded Warrant. 4.2 Form of Series A Warrant. 4.3 Form of Series B Warrant. 5.1 Opinion of Reinhart Boerner Van Deuren s.c. 5.2 Opinion of King & Spalding LLP. 23.1 Consent of Reinhart Boerner Van Deuren s.c. (included in Exhibit 5.1). 23.2 Consent of King & Spalding LLP (included in Exhibit 5.2). 3 99.1 Press Release dated October 29, 2025 announcing the Offering. 99.2 Press Release dated October 30, 2025 announcing the pricing of the Offering. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 4
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 30, 2025 VERU INC. By: /s/ Michele Greco Michele Greco Chief Financial Officer and Chief Administrative Officer 5